Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Comoli

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2003
Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomyFabrizio Ginevri, Nadia Pastorino, Riccardo de Santis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytesPatrizia Comoli, Paolo Pedrazzoli, Rita Maccario, et al.
British Journal of Haematology|November 7, 2008
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia majorMaria Ester Bernardo, Marco Zecca, Eugenia Piras, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donorsPatrizia Comoli, Marco W Schilham, Sabrina Basso, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cellsPatrizia Comoli, Rita Maccario, Franco Locatelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 2, 2023
Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with higher response to fibrogenic signals and might be more pro-inflammatorySara Bozzini, Matteo Della Zoppa, Cecilia Bagnera, et al.
Transplantation|October 27, 2004
Polyomavirus BK-specific immunity after kidney transplantationPatrizia Comoli, Alberta Azzi, Rita Maccario, et al.
Experimental Hematology|October 31, 2003
Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donorsDaniela Montagna, Rita Maccario, Enrica Montini, et al.
Journal of Pediatric Hematology/Oncology|November 7, 2014
Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimenMattia Algeri, Patrizia Comoli, Luisa Strocchio, et al.
Frontiers in Immunology|June 23, 2025
Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantation: study rational and designDaniela Montagna, Patrizia Comoli, Matteo Tanzi, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2003
Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomyFabrizio Ginevri, Nadia Pastorino, Riccardo de Santis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytesPatrizia Comoli, Paolo Pedrazzoli, Rita Maccario, et al.
British Journal of Haematology|November 7, 2008
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia majorMaria Ester Bernardo, Marco Zecca, Eugenia Piras, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donorsPatrizia Comoli, Marco W Schilham, Sabrina Basso, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cellsPatrizia Comoli, Rita Maccario, Franco Locatelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 2, 2023
Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with higher response to fibrogenic signals and might be more pro-inflammatorySara Bozzini, Matteo Della Zoppa, Cecilia Bagnera, et al.
Transplantation|October 27, 2004
Polyomavirus BK-specific immunity after kidney transplantationPatrizia Comoli, Alberta Azzi, Rita Maccario, et al.
Experimental Hematology|October 31, 2003
Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donorsDaniela Montagna, Rita Maccario, Enrica Montini, et al.
Journal of Pediatric Hematology/Oncology|November 7, 2014
Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimenMattia Algeri, Patrizia Comoli, Luisa Strocchio, et al.
Frontiers in Immunology|June 23, 2025
Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantation: study rational and designDaniela Montagna, Patrizia Comoli, Matteo Tanzi, et al.
Pageof 14